Women's values and preferences on low-molecular-weight heparin and pregnancy: a mixed-methods systematic review.

ABSTRACT:

Background

Venous thromboembolism (VTE) in pregnancy is an important cause of maternal morbidity and mortality. Low-molecular-weight heparin (LMWH) is the cornerstone of prophylaxis and treatment of thrombotic events during pregnancy. LMWH has fewer adverse effects than other anticoagulants, does not cross the placenta, and is safe for the fetus. However, the use of LMWH during pregnancy is sensitive to womens' underlying preferences. The objective of this review is to systematically assess women's values and preferences research evidence on this topic.

Methods

We searched four electronic databases from inception to March 2022, and included studies examining values and preferences of using LMWH among pregnant women at risk of VTE. We followed a convergent integrated mixed-me

SUBMITTER: Leon-Garcia M 

PROVIDER: S-EPMC9533610 | biostudies-literature | 2022 Oct

REPOSITORIES: biostudies-literature